You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Broadly Neutralizing

Showing 1 - 25 of 718
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Philadelphia (3BNC117-LS, 10-1074-LS)

Suspended
  • HIV Infections
  • Birmingham, Alabama
  • +5 more
Jan 31, 2023

Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)

Not yet recruiting
  • Human Immunodeficiency Virus
  • New York, New York
  • +2 more
Jul 12, 2022

HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

Not yet recruiting
  • HIV Infections
  • Teropavimab
  • +4 more
  • (no location specified)
Feb 6, 2023

HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

Not yet recruiting
  • HIV-1-infection
  • VRC07-523LS
  • +7 more
  • Pathum Wan, Bangkok, Thailand
  • +1 more
Mar 8, 2023

HIV Infection Trial in United States (N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074)

Recruiting
  • HIV Infection
  • N-803 (IL-15 Superagonist)
  • +2 more
  • Los Angeles, California
  • +11 more
Sep 22, 2022

Broadly HIV-1 Neutralizing Antibodies in HIV-infected Mbeya,

Active, not recruiting
  • HIV/AIDS
    • Mbeya, Tanzania
      NIMR-Mbeya Medical Research Center (MMRC)
    Aug 5, 2022

    Hiv Trial in Denmark, United Kingdom (Romidepsin, 3BNC117, Antiretrovirals)

    Active, not recruiting
    • Hiv
    • Aalborg, Denmark
    • +6 more
    Sep 3, 2021

    HIV-1-infection Trial in Botswana, Malawi, South Africa (3BNC117-LS-J, 10-1074-LS-J, Placebo for 3BNC117-LS-J)

    Not yet recruiting
    • HIV-1-infection
    • Molepolole, Botswana
    • +8 more
    Sep 8, 2023

    HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

    Not yet recruiting
    • HIV-1-infection
    • ChAdOx1.tHIVconsv1
    • +7 more
    • San Diego, California
    • +11 more
    Oct 4, 2023

    HIV/AIDS Trial in San Francisco (Combination Intervention)

    Active, not recruiting
    • HIV/AIDS
    • Combination Intervention
    • San Francisco, California
      Zuckerberg San Francisco General Hospital, University of Califor
    Mar 21, 2022

    HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)

    Unknown status
    • HIV
    • +2 more
    • Pegylated Interferon alpha 2b (peg-IFN-α2b)
    • 3BNC117 + 10-1074
    • Philadelphia, Pennsylvania
    • +1 more
    Jun 22, 2021

    HIV, AIDS, Immunologic Deficiency Syndrome, Acquired Trial in Boston (Ad26.Mos4.HIV, MVA-BN-HIV, PGT121)

    Recruiting
    • HIV
    • +4 more
    • Ad26.Mos4.HIV
    • +4 more
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Apr 18, 2022

    Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)

    Not yet recruiting
    • Acute HIV Infection
    • VRC07-523LS
    • +3 more
    • Birmingham, Alabama
    • +35 more
    Jan 30, 2023

    HIV Trial in Bangkok (VRC01, Placebo for VRC01)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • Placebo for VRC01
    • Bangkok, Thailand
      SEARCH Thai Red Cross AIDS Research Centre Non-Network CRS
    Oct 29, 2021

    HIV-1-infection Trial in Worldwide (Saline, Lefitolimod, 3BNC117 and 10-1074)

    Active, not recruiting
    • HIV-1-infection
    • Salt Lake City, Utah
    • +7 more
    Mar 30, 2022

    Hiv, HIV/AIDS, HIV Trial in San Francisco, Boston, Minneapolis (N-803 and bNAbs, haNK™ Cells)

    Withdrawn
    • Hiv
    • +5 more
    • N-803 and bNAbs
    • haNK™ Cells
    • San Francisco, California
    • +2 more
    Oct 21, 2020

    HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)

    Active, not recruiting
    • HIV-1 Infection
    • Oral Lenacapavir
    • +3 more
    • Los Angeles, California
    • +22 more
    Nov 4, 2022

    HIV-1-infection Trial in Worldwide (3BNC117-LS-J, 10-1074-LS-J, Combination 3BNC117-LS-J and 10-1074-LS-J)

    Unknown status
    • HIV-1-infection
    • 3BNC117-LS-J
    • +6 more
    • Boston, Massachusetts
    • +8 more
    Dec 11, 2020

    HIV Trial in Worldwide (GSK3810109A)

    Active, not recruiting
    • HIV Infections
    • GSK3810109A
    • Long Beach, California
    • +24 more
    Nov 30, 2022

    HIV Trial in Worldwide (VRC01, Placebo for VRC01)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • Placebo for VRC01
    • Gaborone, South-East District, Botswana
    • +20 more
    Feb 8, 2022

    HIV Trial in Worldwide (VRC01, Placebo for VRC01)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • Placebo for VRC01
    • Birmingham, Alabama
    • +25 more
    Feb 8, 2022

    HIV-1 Trial in Puerto Rico, United States (VRC-HIVMAB080-00-AB, VRC-HIVMAB075-00-AB)

    Completed
    Has Results
    • HIV-1
    • VRC-HIVMAB080-00-AB
    • VRC-HIVMAB075-00-AB
    • Birmingham, Alabama
    • +6 more
    Feb 8, 2021

    HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)

    Withdrawn
    • HIV Infection
    • Analytical Treatment Interruption + bNAbs infusion
    • Milan, Lombardy, Italy
    • +3 more
    Aug 2, 2022

    HIV Trial in Columbus, Pittsburgh (Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, Placebo control for Trimer 4571 vaccine

    Recruiting
    • HIV Infections
    • Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant
    • +3 more
    • Columbus, Ohio
    • +1 more
    Apr 10, 2022

    HIV Trial (Low dose KL-HIV-Tri01, Middle dose KL-HIV-Tri01, High dose KL-HIV-Tri01)

    Not yet recruiting
    • HIV Infections
    • Low dose KL-HIV-Tri01
    • +2 more
    • (no location specified)
    Nov 5, 2023